However, the GLP-1 saga turns out, the fact that these drugs have popped up seemingly out of nowhere, and have generated such excitement, highlights the potential existing in the huge repurposed drug (drugs used in another condition than for which they are approved) market for these diseases
JAMA 282 , 15681575 (1999)
What is a dual and triple agonist and why does it matter
[DOI] [PubMed] [Google Scholar] 10
they are intricate, folded chains of amino acids that demand respect
The Role of Technology in Supporting Industry Shifts As businesses in telehealth, fitness, apparel, insurance, nutrition, and data management adapt to the rise of GLP-1 drugs, technology plays a pivotal role in their success